KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $542.0 million.

  • Amgen's Shares Outstanding (Diluted Average) rose 18.48% to $542.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $542.0 million, marking a year-over-year increase of 18.48%. This contributed to the annual value of $542.0 million for FY2025, which is 18.48% up from last year.
  • Per Amgen's latest filing, its Shares Outstanding (Diluted Average) stood at $542.0 million for Q4 2025, which was up 18.48% from $542.0 million recorded in Q3 2025.
  • In the past 5 years, Amgen's Shares Outstanding (Diluted Average) ranged from a high of $581.0 million in Q1 2021 and a low of $536.0 million during Q1 2024
  • For the 5-year period, Amgen's Shares Outstanding (Diluted Average) averaged around $548.2 million, with its median value being $541.5 million (2022).
  • Per our database at Business Quant, Amgen's Shares Outstanding (Diluted Average) tumbled by 590.28% in 2022 and then soared by 93.28% in 2025.
  • Over the past 5 years, Amgen's Shares Outstanding (Diluted Average) (Quarter) stood at $573.0 million in 2021, then decreased by 5.58% to $541.0 million in 2022, then decreased by 0.55% to $538.0 million in 2023, then rose by 0.56% to $541.0 million in 2024, then rose by 0.18% to $542.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $542.0 million for Q4 2025, versus $542.0 million for Q3 2025 and $541.0 million for Q2 2025.